KLP Kapitalforvaltning AS Has $4.08 Million Stock Holdings in DaVita Inc. $DVA

KLP Kapitalforvaltning AS boosted its position in shares of DaVita Inc. (NYSE:DVA) by 1.1% in the second quarter, Holdings Channel.com reports. The firm owned 28,614 shares of the company’s stock after purchasing an additional 300 shares during the period. KLP Kapitalforvaltning AS’s holdings in DaVita were worth $4,076,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of DVA. UMB Bank n.a. boosted its position in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company’s stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. National Pension Service boosted its position in DaVita by 74.3% during the first quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after purchasing an additional 84 shares during the last quarter. Y.D. More Investments Ltd acquired a new stake in DaVita during the first quarter valued at $35,000. Ameritas Advisory Services LLC acquired a new stake in DaVita during the second quarter valued at $47,000. Finally, NewEdge Advisors LLC boosted its position in DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after purchasing an additional 88 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the business’s stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider directly owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.50% of the stock is owned by corporate insiders.

DaVita Stock Performance

DaVita stock opened at $123.91 on Friday. The business’s 50-day simple moving average is $133.26 and its 200-day simple moving average is $139.33. The firm has a market capitalization of $8.86 billion, a PE ratio of 12.18, a PEG ratio of 0.91 and a beta of 1.13. DaVita Inc. has a 52 week low of $123.13 and a 52 week high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same period in the previous year, the company posted $2.00 earnings per share. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DVA has been the subject of a number of research reports. Bank of America reduced their price objective on DaVita from $145.00 to $140.00 and set an “underperform” rating for the company in a research report on Wednesday, September 10th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a research report on Wednesday. Barclays reduced their price target on DaVita from $160.00 to $149.00 and set an “equal weight” rating for the company in a research report on Thursday. Truist Financial set a $148.00 price target on DaVita in a research report on Friday, August 8th. Finally, Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a research report on Saturday. Four equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, DaVita presently has a consensus rating of “Reduce” and an average target price of $155.25.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.